These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6154456)

  • 1. Clinical trials in cancer medicine.
    Snyder RD; Schwarz MA
    Aust Fam Physician; 1980 Jan; 9(1):23-6. PubMed ID: 6154456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
    Heuson JC; Sylvester R; Engelsman E
    Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
    Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma.
    Belani CP
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):25-33. PubMed ID: 15726531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of third-generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review.
    Poole R; Paridaens R
    Curr Opin Oncol; 2007 Nov; 19(6):564-72. PubMed ID: 17906453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of induction and maintenance chemotherapy in disseminated testicular non-seminomatous cancer.
    van Groeningen CJ; Stoter G
    Prog Clin Biol Res; 1984; 153():225-32. PubMed ID: 6206508
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug resistance in chemotherapy for breast cancer.
    Saeki T; Tsuruo T; Sato W; Nishikawsa K
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of post-chemotherapy tamoxifen in early breast cancer.
    Tolcher AW
    Oncology (Williston Park); 1994 Nov; 8(11):39-43; discussion 47-9. PubMed ID: 7826838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
    Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
    Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some drugs for treating neoplasms.
    Healy JB
    Ir Med J; 1978 May; 71(8):264-7. PubMed ID: 77265
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of VM26, mitomycine C, methotrexate in patients with metastatic carcinoma of the breast resistant to a combination of 4 drugs including adriamycin. Results of a type II study (autohr's transl)].
    Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Magdelenat H
    Nouv Presse Med; 1979 Aug 25-Sep 3; 8(33):2690. PubMed ID: 493073
    [No Abstract]   [Full Text] [Related]  

  • 14. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
    Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
    J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential combination chemotherapy with vinblastine-bleomycin and doxorubicin-cis-dichlorodiammineplatinum(II) in disseminated nonseminomatous testicular cancer.
    Scheulen ME; Seeber S; Schilcher RB; Meier CR; Schmidt CG
    Cancer Treat Rep; 1980; 64(4-5):599-609. PubMed ID: 6159077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New antineoplastic drugs of the podophyllotoxin derivative group].
    Robak T; Płuzańska A
    Pol Tyg Lek; 1983 Jan; 38(1):27-30. PubMed ID: 6346283
    [No Abstract]   [Full Text] [Related]  

  • 19. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
    Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
    Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to endocrine therapy for breast cancer.
    Chlebowski RT; Geller ML
    Oncology; 2006; 71(1-2):1-9. PubMed ID: 17344666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.